ANI Pharmaceuticals, Inc. delivered robust 2025 results and issued bullish 2026 guidance. Learn more about ANIP stock here.
The Chosun Ilbo on MSN
Ani halts singing, returns to Columbia University
Ani (real name Moon Seo-yoon), a member of the group Allday Project, will temporarily halt her singing activities and return ...
Amid the dozens of publicly traded firms in Minnesota, Baudette-based ANI Pharmaceuticals Inc. often flies under the radar. The pharmaceutical company about five hours north of Minneapolis has grown ...
StockStory.org on MSN
ANI Pharmaceuticals (ANIP) stock trades down, here is why
What Happened? Shares of specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) fell 3.3% in the morning session ...
ANI is growing its capabilities and pipeline with an acquisition. The company has signed a definitive agreement to acquire Novitium Pharma for $163.5 million, including $89.5 million in cash and $74 ...
ANI is expanding its portfolio of branded drugs. The company has acquired the new drug applications from Sandoz for Oxistat lotion, Veregen ointment, and Pandel cream and the abbreviated new drug ...
ANI Pharmaceuticals (ANIP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, and contract manufacturing. Despite cash burn concerns, ANI's revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback